论文部分内容阅读
目的了解新疆开展伴侣艾滋病咨询检测(CHCT)试点的接受程度,分析其影响因素。方法开展宣传动员及转介,针对求询者及其伴侣需求,提供相应的艾滋病病毒(HIV)咨询检测服务,并将求询者及其伴侣的信息进行统一个案记录。结果 2012年,共有1511名求询者及其伴侣接受HIV咨询检测服务,其中,HIV感染者/AIDS病人(简称HIV/AIDS病人)及其伴侣977对,高危行为者及其伴侣534对。求询者以汉族及维吾尔族为主,分别占15.8%(238人)和81.8%(1236人),伴侣民族构成与求询者基本一致。求询者平均年龄为(34±9.5)岁,伴侣平均年龄为(33±8.867)岁。求询者及其伴侣的性别为:男-男113对(7.5%),男-女1034对(68.43%),女-男364对(24.1%)。HIV感染状况为:双阳67对,双阴466对,单阳962对。求询者接受CHCT的比率为66.38%(1003对);汉族、年龄较轻、尚未共同生活以及HIV检测为阴性的求询者更容易接受CHCT。接受CHCT后性病抗结核转介、社会关爱救助转介的比率分别是7.9%和14.9%,高于未接受CHCT者。结论 CHCT可以被HIV/AIDS病人、高危人群及其性伴侣所接受。通过CHCT,可以为性伴侣双方提供更多的治疗和关怀服务。
Objective To understand the acceptability of CHCT pilots in Xinjiang and analyze the influencing factors. Methods To carry out advocacy mobilization and referral, provide corresponding HIV counseling and testing services according to the needs of the inquirers and their partners, and record the information of the inquirers and their companions in a unified way. Results In 2012, a total of 1,511 inquirers and their partners received HIV counseling and testing services. Among them, 977 were HIV / AIDS patients (AIDS / AIDS patients) and their companions, 534 were high risk carriers and their partners. Inquirers were mainly Han and Uygur ethnic groups, accounting for 15.8% (238 persons) and 81.8% (1236 persons) respectively. The ethnic composition and inquires of their partners were basically the same. The average age of interrogation was (34 ± 9.5) years old and the average age of the couple was (33 ± 8.867) years old. The sexes of the inquirers and their mates were: 113 males (7.5%), 1034 males to females (68.43%), and 364 females to males (24.1%). HIV infection status: Shuangyang 67 pairs, Shuangyin 466 pairs, 962 pairs of single Yang. The percentage of respondents who accepted CHCT was 66.38% (1003 pairs); CHTR was more likely to be accepted by Han, younger patients, those who had not lived together and were HIV negative. The rates of referrals for STDs and STDs after CHCT were 7.9% and 14.9% respectively, which were higher than those who did not receive CHCTs. Conclusion CHCT can be accepted by HIV / AIDS patients, high-risk groups and their sexual partners. Through CHCT, more treatment and care services can be provided to both partners.